Apolipoprotein E gene polymorphism in renal transplant recipients: effects on lipid metabolism, atherosclerosis and allograft function
- 10 May 2004
- journal article
- Published by Wiley in Clinical Transplantation
- Vol. 18 (3) , 288-294
Abstract
Atherosclerosis is a serious complication and leading cause of mortality in renal transplant recipients (RTRs). Hyperlipidemia may be associated with progression of renal disease and chronic allograft dysfunction. Similarities in the pathogenesis of glomerulosclerosis and atherosclerosis have been proposed. Apolipoprotein (apo) E gene code forms three major isoforms (E2, E3, and E4) with variable effects on lipid metabolism. A total of 118 patients, at a mean age of 40 +/- 8 yr, were included in the study. Apo E genotyping was carried out on genomic DNA using polymerase chain reaction and restriction enzyme. Carotid artery intima media thickness and atherosclerotic plaques were evaluated by B-mode ultrasonography. The plasma levels of lipids and lipoproteins and acute phase reactants were also studied. Allograft function was evaluated by measuring serum creatinine and creatinine clearance values. The frequencies of E2, E3, and E4 alleles were 0.10, 0.78, and 0.12 respectively. Carotid artery atherosclerosis was found in 25% of E2 carriers, 30% of E3 carriers, and 57% of E4 carriers. Total cholesterol, total triglyceride, low-density lipoprotein, very low-density lipoprotein, apo B 100 levels were found to be higher in apo E4 carriers. Median apo A1 level was higher and allograft functions were better in apo E2 carriers (p < 0.05). Multiple regression analysis showed that allograft functions were negatively correlated with elevated acute phase reactants (p < 0.01) and only the age, but not the apo E genotypes, was an independent risk factor for atherosclerotic vascular disease (p < 0.01). The pathogenetic events linking lipid metabolism and allograft functions and development of atherosclerosis are complex and multifactorial in RTRs. Our results showed that apo E genotypes have influences on lipids, lipoproteins and allograft functions. The ultimate role of apo E4 gene polymorphism as a risk factor for development and progression of atherosclerosis in RTRs should be sought in further studies.Keywords
This publication has 27 references indexed in Scilit:
- Effects of apolipoprotein E genotypes and other risk factors on the development of coronary artery disease in Southern TurkeyClinica Chimica Acta, 2001
- Increased Prevalence of Apolipoprotein E3/E4 Genotype among Swedish Renal Transplant RecipientsNephron, 1999
- Carotid atherosclerosis in renal transplant recipientsNephrology Dialysis Transplantation, 1998
- The influence of pretransplant lipoprotein abnormalities on the early results of renal transplantationEuropean Journal of Clinical Investigation, 1993
- Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects.Journal of Clinical Investigation, 1991
- Apolipoprotein E genotyping by one-stage PCRThe Lancet, 1991
- Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell BiologyScience, 1988
- A simple salting out procedure for extracting DNA from human nucleated cellsNucleic Acids Research, 1988
- Apolipoprotein E polymorphism and atherosclerosis.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
- Deaths from Occlusive Arterial Disease in Renal Allograft RecipientsBMJ, 1974